Our office will be closed on Friday 18th April and Monday 21st April. Happy Easter!
FreeStyle Libre 2 have been upgraded to FreeStyle Libre 2 Plus. There is a price increase which directly relates to the additional day of wear time which is 15 days.
Menu
X
Extended 15-day wear time and improved accuracy!*,1
For even more convenience and value, FreeStyle Libre 2 Plus sensors feature a 15-day wear time.
With improved accuracy' and glucose readings every minute, make treatment decisions with even more confidence.
For people living with diabetes (aged 2+)
FreeStyle Libre 2 Plus sensors is now available in New Zealand for people living with diabetes aged 2 and over. Now, even more people can take advantage of the life-changing insights that the FreeStyle Libre 2 system provides, even if they are not using insulin!
Wear duration
Size
Indicated for use
Reader / App compatibility
FreeStyle Libre 2 Plus Sensor
Wear duration
15 Days
Size
35 x 5mm
Indicated for use
All people living with diabetes aged 2+
Reader / App compatibility
FreeStyle LibreLinkØ, LibreLinkUp Ω , FreeStyle Libre 2 reader
FreeStyle Libre 2 Sensor
Wear duration
14 days
Size
35 x5mm
Indicated for use
People with insulin- dependent diabetes, aged 4+
Reader / App compatibility
FreeStyle LibreLinkØ, LibreLinkUp Ω , FreeStyle Libre 2 reader
Explore the FreeStyle Libre system with these bite-sized videos
Freestyle Libre Support
0800 106 100 option 2 /
(NZ Only) 9am - 7pm seven days a week.
The FreeStyle Libre 2 Plus sensor is Abbott's latest innovation, with the following new features/upgrades from the FreeStyle Libre 2 sensor:
a. Extended 15-day sensor wear time
b. For people living with diabetes (aged 2+)
c. Improved accuracy',1
The FreeStyle Libre 2 Plus sensor will be compatible with the FreeStyle LibreLink app and FreeStyle Libre 2 Reader
NZ $99.46+ GST
The FreeStyle Libre 2 Plus sensor will be available on the Pharmac CGM funding scheme from 1 May 2025.
Please note the FreeStyle Libre 2 sensor will be removed from the Pharmac CGM funding scheme in November 2025.
The FreeStyle Libre 2 Plus System is indicated for measuring interstitial fluid glucose levels in people (aged 2+) with diabetes. Always read the instructions for use. The sensor must be removed prior to Magnetic Resonance Imaging (MRI).
The FreeStyle Libre 2 Plus sensor is indicated for people with diabetes aged 2 or older. This means it can be used by anyone living with diabetes, regardless of whether their treatment includes insulin. Please consult with your healthcare professional as to whether the FreeStyle Libre 2 Plus sensor is right for you.
Yes, FreeStyle Libre 2 Plus sensors can be used by people who are living with gestational diabetes. Please consult with your healthcare professional as to whether the FreeStyle Libre 2 Plus sensor is right for you.
Yes, FreeStyle Libre 2 Plus sensors can be used while pregnant. If you have been living with diabetes and using FreeStyle Libre 2 Plus sensors, you can continue usage if you become pregnant. If you are diagnosed with any form of diabetes during pregnancy you can commence using FreeStyle Libre 2 Plus sensors. Please consult with your healthcare professional as to whether FreeStyle Libre 2 Plus sensors are right for you.
The FreeStyle Libre 2 sensor is no longer available to purchase from Mediray.co.nz.
The FreeStyle Libre 2 Plus sensor is the latest innovation to the FreeStyle Libre 2 system and is now available to purchase from FreeStyleLibre.co.nz.
The FreeStyle Libre 2 sensor will be removed from the Pharmac CGM funding scheme in November 2025.
The new FreeStyle Libre 2 Plus sensor will be available on the Pharmac CGM funding scheme from 1 May 2025.
If you are using the latest version of the FreeStyle LibreLinkØ app, you will not have to update your app as the FreeStyle Libre 2 Plus sensor is a sensor hardware update. The FreeStyle Libre 2 Plus sensor is compatible with the current FreeStyle LibreLinkØ app and FreeStyle Libre 2 Reader.
No. LibreLinkUpΩ app users will not have to update their app.
LibreLinkUpΩ app users will receive a push notification informing them that their connection has started a new sensor. However, it will not specify whether it is the FreeStyle Libre 2 sensor or FreeStyle Libre 2 Plus sensor.
The FreeStyle Libre 2 Plus System is indicated for measuring interstitial fluid glucose levels in people (aged 2+) with diabetes. Always read the instructions for use. The sensor must be removed prior to Magnetic Resonance Imaging (MRI).
The FreeStyle Libre 2 System is indicated for measuring interstitial fluid glucose levels in people (aged 4+) with insulin-dependent diabetes. Always read the instructions for use. The system must not be used with automated insulin dosing (AID) systems, including closed-loop and insulin suspend systems. The sensor must be removed prior to Magnetic Resonance Imaging (MRI).
* Compared to other on-market CGMs in New Zealand. As of Dec 2024.
♢ Data based on the number of users worldwide for FreeStyle Libre family of personal CGMs compared to the number of users for other leading personal CGM brands and based on CGM sales dollars compared to other leading personal CGM brands.
Ø The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check www. freestylelibre.com.au/compatibility for more
information about device compatibility before using the app. Use of FreeStyle Librelink requires registration with LibreView.
Ω The LibreLink Up app is only compatible with certain mobile device and operating systems. Please check www.librelinkup.com for more information about device
compatibility before using the app. Use of LibreLink Up and FreeStyle LibreLink requires registration with LibreView.The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
♣ The LibreView website is only compatible with certain operating systems and browsers. Please check www.libreview.com for additional information.
1. U.S. Food and Drug Administration (FDA). 510(k) K222447. 2023. https://www.accessdata.fda.gov/cdrh_docs/reviews/K222447.pdf. Accessed 1 Dec 2024. Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc., registered in the U.S. and other
countries. Google Play and the Google Play logo are trademarks of Google LLC
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Information contained herein is for distribution outside of the USA only.
ADC-106879 V2.0